← Back to Patent Explorer
US5134232A Expired / Lapsed US ⏱️ 0.0 years remaining

Fluorescent indicator dyes for alkali metal cations

Assignee: University of California
•
Filing: 1989-08-09
•
Granted: 1992-07-28
•
Expires: 2009-08-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention discloses fluorescent chelator compounds that are especially useful to monitor and measure cytosolic concentrations of alkali metal cations such as Na+, K+, and Li+. The new compounds are comprised of: (1) crown ethers (that may or may not have substituent groups attached to the core carbons, but will always contain at least one core nitrogen) that are linked via the core nitrogen(s) to at least one (2) fluorophore that contains an additional heteroaromatic liganding center. In the currently preferred dye, SBFI, the core compound is crown ether 1,7-diaza-4,10,13-trioxacyclopentadecane and the heteroaromatic fluorophores are benzofurans that are linked to isophthalate groups. Selectivities for Na+ over K+ of about 20 are observed, resulting in effective dissociation constants for Na+ of about 20 mM against a background of 120 mM K+. Increasing [Na+] increases the ratio of excitation efficiency at 330-345 nm to that at 370-390 nm with emission collected at 450-550 nm, so that ratio fluorometry and imaging work at the same wavelengths as used with the well-known Ca2+ indicator fura-2. If the macrocyclic ring is increased in size to a 1,10-diaza-4,7,13,16-tetraoxacyclooctadecane, the chelators become selective for K+ over Na+. If the ring is decreased in size, for example to a 1,7-diaza-4,10-dioxacyclododecane, the chelators become selective for Li+ over Na+.

Inventors

  • 👤 Roger Y. Tsien
  • 👤 Akwasi Minta

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 17:35
CPC Classifications
C; C07; C07D; C07D273/00; C07D413/00; C07D413/02; C07D413/04; C07D413/14; C07D491/00; C07D491/02; C07D491/04; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/84

Claims Analysis

Total Claims: 28
Claim 1
Independent Claim 16 words
The compound SBFI, having the structure: ##STR13## and the physiologically acceptable non-toxic esters and salts thereof.
Claim 2
Dependent Claim 16 words
The compound SBFI, having the structure: ##STR13## and the physiologically acceptable non-toxic esters and salts thereof.
Claim 3
Dependent Claim 16 words
The compound PBFI, having the structure: ##STR14## and the physiologically acceptable non-toxic esters and salts thereof.
Claim 4
Dependent Claim 16 words
The compound PBFI, having the structure: ##STR14## and the physiologically acceptable non-toxic esters and salts thereof.
Claim 5
Dependent Claim 11 words
The compound of claim 1 as the physiologically acceptable non-toxic ester.
Claim 6
Dependent Claim 12 words
The compound of claim 3 as the physiologically acceptable non-toxic acetoxymethyl ester.
Claim 7
Dependent Claim 11 words
The compounds of claim 1 as the physiologically acceptable non-toxic salt.
Claim 8
Dependent Claim 12 words
The compound of claim 2 as the physiologically acceptable non-toxic free acid.
Claim 9
Dependent Claim 11 words
The compound of claim 2 as the physiologically acceptable non-toxic ester.
Claim 10
Dependent Claim 12 words
The compound of claim 7 as the physiologically acceptable non-toxic acetoxymethyl ester.
Claim 11
Dependent Claim 11 words
The compounds of claim 2 as the physiologically acceptable non-toxic salt.
Claim 12
Dependent Claim 61 words
A compound or the physiologically acceptable non-toxic methyl, ethyl or acetoxylmethyl esters or salts thereof wherein said compound is selected from the group consisting of: ##STR15## wherein Ar groups in structure 2 are identical and are selected from the group consisting of: ##STR16## wherein the Ar groups in structure 3 are identical and are selected from the group consisting of ##STR17##
Claim 13
Dependent Claim 61 words
A compound or the physiologically acceptable non-toxic methyl, ethyl or acetoxylmethyl esters or salts thereof wherein said compound is selected from the group consisting of: ##STR15## wherein Ar groups in structure 2 are identical and are selected from the group consisting of: ##STR16## wherein the Ar groups in structure 3 are identical and are selected from the group consisting of ##STR17##
Claim 14
Dependent Claim 12 words
The compound of claim 10 as the physiologically acceptable non-toxic free acid.
Claim 15
Dependent Claim 11 words
The compound of claim 10 as the physiologically acceptable non-toxic ester.
Claim 16
Dependent Claim 12 words
The compound of claim 10 as the physiologically acceptable non-toxic acetoxymethyl ester.
Claim 17
Dependent Claim 11 words
The compound of claim 10 as the physiologically acceptable non-toxic salt.
Claim 18
Dependent Claim 131 words
A compound or the pharmaceutically acceptable physiologically hydrolyzable esters or salts thereof, wherein said compound is selected from the group consisting of: ##STR18## wherein the Ar groups in structure 2 are not identical and are selected from the group consisting of: ##STR19## with the proviso that when one Ar group is selected from C, D, E, F, G or H, the other Ar group is selected from J, K, L, M, N, O or P; and ##STR20## wherein the Ar groups in structure 3 are not identical and are selected from the group consisting of: ##STR21## with the proviso that when one Ar group is selected from group C, D, E, F, G and H, the other Ar group is selected from group J, K, L, M, N, O or P.
Claim 19
Dependent Claim 131 words
A compound or the pharmaceutically acceptable physiologically hydrolyzable esters or salts thereof, wherein said compound is selected from the group consisting of: ##STR18## wherein the Ar groups in structure 2 are not identical and are selected from the group consisting of: ##STR19## with the proviso that when one Ar group is selected from C, D, E, F, G or H, the other Ar group is selected from J, K, L, M, N, O or P; and ##STR20## wherein the Ar groups in structure 3 are not identical and are selected from the group consisting of: ##STR21## with the proviso that when one Ar group is selected from group C, D, E, F, G and H, the other Ar group is selected from group J, K, L, M, N, O or P.
Claim 20
Dependent Claim 12 words
The compound of claim 15 as the physiologically acceptable non-toxic free acid.
Claim 21
Dependent Claim 11 words
The compound of claim 15 as the physiologically acceptable non-toxic ester.
Claim 22
Dependent Claim 12 words
The compound of claim 15 as the physiologically acceptable non-toxic acetoxymethyl ester.
Claim 23
Dependent Claim 11 words
The compound of claim 15 as the physiologically acceptable non-toxic salt.
Claim 24
Dependent Claim 32 words
The compound of claim 15 wherein one Ar group is selected from groups C, D, E, F, G, H or I, the other group is selected from groups N, O or P.
Claim 25
Dependent Claim 12 words
The compound of claim 20 as the physiologically acceptable non-toxic free acid.
Claim 26
Dependent Claim 11 words
The compound of claim 20 as the physiologically acceptable non-toxic ester.
Claim 27
Dependent Claim 12 words
The compound of claim 20 as the physiologically acceptable non-toxic acetoxymethyl ester.
Claim 28
Dependent Claim 11 words
The compound of claim 20 as the physiologically acceptable non-toxic salt.

References Cited (Backward Citations)

US4597903A Cited
US4927923A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-07-28 1996-01-27 1996-07-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-07-28 2000-01-27 2000-07-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-07-28 2004-01-27 2004-07-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag